Skip to main content
Clinical Trials/NCT01496859
NCT01496859
Completed
Phase 2

Observational Study of Baska Mask, a New Supraglottic Airway Device

University College Hospital Galway1 site in 1 country30 target enrollmentAugust 2011

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Performance and Safety of a New Supraglottic Airway Device
Sponsor
University College Hospital Galway
Enrollment
30
Locations
1
Primary Endpoint
Device Placement Success rate
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The Baska mask is a new supraglottic airway device . The investigators would like to assess its performance in setting in which the current standard - LMA device - is being used.

Detailed Description

Our group has performed a number of studies on novel airway devices. In this study we would like to evaluate a new supraglottic airway named Baska mask. We would like to monitor certain parameters (time to and ease of insertion, failure rate, seal pressures, complications etc) as regarding the performance and safety profile of this device. This is a descriptive case series of patients undergoing airway management under general anaesthesia.

Registry
clinicaltrials.gov
Start Date
August 2011
End Date
December 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
University College Hospital Galway
Responsible Party
Principal Investigator
Principal Investigator

John Laffey

Professor of Anaesthesia and Critical Care, Consultant Anaesthetist

University College Hospital Galway

Eligibility Criteria

Inclusion Criteria

  • Written informed Consent
  • No relevant drug allergies
  • Body-mass index (BMI) 20-35
  • Age 18-65
  • Non-urgent surgery of planned duration 0-2 hrs

Exclusion Criteria

  • Inability of patient/parent to understand or consent for the trial
  • Non-English speakers
  • Neck pathology
  • Previous or anticipated problems with the upper airway or upper GI tract (reflux, hiatus hernia, oropharyngeal tumour, upper respiratory tract infection in the last 10 days etc)
  • Expected Difficult airway
  • Live Pregnancy
  • Increased risk for Gastric Aspiration

Outcomes

Primary Outcomes

Device Placement Success rate

Time Frame: within 30 mins of anaesthesia commencement

time to placement of device

Time Frame: within 30 mins of anaesthesia commencement

from the moment the device touched until successful ventilation achieved or device removed

Secondary Outcomes

  • user-rated ease of insertion of device(within 30 mins of anaestesia commencement)
  • airway leak pressure of the device(within 30 mins of anaesthetic commencement)
  • complication rates(From the moment general anaesthesia commenced up to 1 day postoperatively)
  • patient comfort indices(from the moment the patient awake up to 1 day postoperatively)

Study Sites (1)

Loading locations...

Similar Trials